Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Concetta Quintarelli

15PUBLICATIONS
98CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Mar 03, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Marco Becilli, Pietro Merli, Mattia Algeri

|Aug 19, 2025
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Swati Naik, Richard Aplenc, Susanne H C Baumeister

|Jun 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse.

Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli

|Jun 13, 2024
GD2 Target Antigen and CAR T Cells: Does It Take More Than Two to Tango?

Franco Locatelli, Concetta Quintarelli

|Mar 29, 2024
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.

Roselia Ciccone, Concetta Quintarelli, Antonio Camera

|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL.

Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli

Pageof 3

Frequent Collaborators

7 joint publications

Biagio De Angelis

7 joint publications

Franco Locatelli

7 joint publications

Francesca Del Bufalo

4 joint publications

Stefano Di Cecca

4 joint publications

Marco Becilli

4 joint publications

Pietro Merli

3 joint publications

Valentina Bertaina

2 joint publications

Matilde Sinibaldi

2 joint publications

Stephen Gottschalk

2 joint publications

Ignazio Caruana

Frequent Collaborators

7 joint publications

Biagio De Angelis

7 joint publications

Franco Locatelli

7 joint publications

Francesca Del Bufalo

4 joint publications

Stefano Di Cecca

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

21.5K
Clinical Application of <em>Sleeping Beauty</em> and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of <em>Sleeping Beauty</em> and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on : Feb 01, 2013

18.6K
See more related videos

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

21.5K
Clinical Application of <em>Sleeping Beauty</em> and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of <em>Sleeping Beauty</em> and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on : Feb 01, 2013

18.6K
See more related videos